Similarly, Patients B6 and B7 had mutations in AASS, which would explain the hyperlysinaemia seen in both plasma and CSF but not the presence of developmental delay, microcephaly, hypotonia and epilepsy (Houten et al., 2013). The gene discussed is AASS; the disease is Global developmental delay.